Sandler Alan B.insider trades
In SEC Form 4 filings, Sandler Alan B. is listed as Chief Development Officer of Revolution Medicines, Inc. (RVMD). In the last 90 days, Sandler Alan B. sold $1.34M of Revolution Medicines, Inc. (RVMD) on the open market and bought none. All 7 sales were reported under a 10b5-1 trading plan.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| RVMDRevolution Medicines, Inc. | Chief Development Officer | 9 | Oct 1 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-09-18
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| RVMDRevolution Medicines, Inc. | Sep 29 | Oct 1 | M | 6,000 | $58.84 | $353,040 | 58,868 | Yes | Form 4 |
| RVMDRevolution Medicines, Inc. | Sep 29 | Oct 1 | S | 2,200 | $200.82 | Sale −$441,801 | 56,668 | Yes | Form 4 |
| RVMDRevolution Medicines, Inc. | Sep 29 | Oct 1 | S | 1,609 | $201.72 | Sale −$324,574 | 55,059 | Yes | Form 4 |
| RVMDRevolution Medicines, Inc. | Sep 29 | Oct 1 | S | 1,000 | $202.81 | Sale −$202,813 | 54,059 | Yes | Form 4 |
| RVMDRevolution Medicines, Inc. | Sep 29 | Oct 1 | S | 1,199 | $203.91 | Sale −$244,485 | 52,860 | Yes | Form 4 |
| RVMDRevolution Medicines, Inc. | Sep 29 | Oct 1 | S | 301 | $204.72 | Sale −$61,621 | 52,559 | Yes | Form 4 |
| RVMDRevolution Medicines, Inc. | Sep 29 | Oct 1 | M · derivative | 6,000 | $58.84 | $353,040 | 161,300 | Yes | Form 4 |
| RVMDRevolution Medicines, Inc. | Sep 16 | Sep 18 | S | 5 | $194.96 | Sale −$975 | 53,204 | Yes | Form 4 |
| RVMDRevolution Medicines, Inc. | Sep 16 | Sep 18 | S | 336 | $199.30 | Sale −$66,966 | 52,868 | Yes | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.